Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 195 entries
View as:

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06904170 Org: User:
Start: 09/30/25 End: 09/30/30 Due: 09/30/31

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT01442649 Org: User:
Start: 12/31/10 End: 12/31/17 Due: 12/31/18

Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03080428 Org: User:
Start: 05/31/17 End: 05/31/23 Due: 05/31/24

Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

Phase: N/A Priority: Normal
NCT ID: NCT06078384 Org: User:
Start: 12/27/24 End: 01/01/32 Due: 01/01/33

A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project

Phase: N/A Priority: Normal
NCT ID: NCT03320161 Org: User:
Start: 10/10/18 End: 05/26/21 Due: 05/26/22

Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02773004 Org: User:
Start: 09/30/16 End: 12/31/17 Due: 12/31/18

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00053911 Org: User:
Start: 11/30/02 End: - Due: -

PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03774732 Org: User:
Start: 01/24/18 End: 07/22/27 Due: 07/22/28

Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)

Phase: N/A Priority: Normal
NCT ID: NCT02404935 Org: User:
Start: 11/22/13 End: 10/25/21 Due: 10/25/22

Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04158362 Org: User:
Start: 06/11/20 End: 06/30/28 Due: 06/30/29

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003650 Org: User:
Start: 02/28/97 End: 11/30/13 Due: 11/30/14

Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03532204 Org: User:
Start: 04/15/19 End: 08/15/23 Due: 08/15/24

Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00217607 Org: User:
Start: 02/28/05 End: 01/31/12 Due: 01/31/13

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00227747 Org: User:
Start: 11/08/05 End: 07/15/13 Due: 07/15/14

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002870 Org: User:
Start: 12/31/94 End: 01/31/02 Due: 01/31/03

Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT00006119 Org: User:
Start: 07/31/99 End: 01/31/08 Due: 01/31/09

Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative

Phase: N/A Priority: Normal
NCT ID: NCT02754011 Org: User:
Start: 02/02/17 End: 12/23/22 Due: 12/23/23

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00104676 Org: User:
Start: 11/26/03 End: 02/08/23 Due: 02/08/24

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

Phase: N/A Priority: Normal
NCT ID: NCT01952223 Org: User:
Start: 12/31/13 End: 07/31/41 Due: 07/31/42

Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002566 Org: User:
Start: 02/28/94 End: 12/31/03 Due: 12/31/04

Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT02304809 Org: User:
Start: 10/13/14 End: 10/13/27 Due: 10/13/28

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01313377 Org: User:
Start: 07/31/09 End: 06/30/16 Due: 06/30/17

Tracking Triple-negative Breast Cancer Evolution Through Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03077776 Org: User:
Start: 04/14/17 End: 05/31/26 Due: 05/31/27

Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01262469 Org: User:
Start: 12/31/09 End: 11/30/13 Due: 11/30/14

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006051 Org: User:
Start: 02/28/99 End: 09/30/05 Due: 09/30/06